Broker Recommendations

07/07 UBS Adjusts Price Target on Altria Group to $79 From $76 MT
27/05 Jefferies Adjusts Price Target on Altria to $60 From $50, Maintains Underperform Rating MT
15/05 Barclays Adjusts Price Target on Altria Group to $64 From $63, Maintains Underweight Rating MT
04/05 Deutsche Bank Adjusts Altria Group Price Target to $66 From $60, Maintains Hold Rating MT
01/05 Altria Shows Solid Profit Momentum Amid Structural Headwinds, Morgan Stanley Says MT
01/05 UBS Adjusts Price Target on Altria to $76 From $74, Maintains Buy Rating MT
01/05 Citigroup Adjusts Altria Price Target to $70 From $65, Maintains Neutral Rating MT
01/05 Goldman Sachs Adjusts Altria Price Target to $77 From $72, Maintains Buy Rating MT
01/05 Stifel Nicolaus Adjusts Altria Price Target to $77 From $68, Maintains Buy Rating MT
01/05 Morgan Stanley Raises Price Target on Altria Group to $71 From $62, Keeps Equalweight Rating MT
23/04 Altria Q1 Beat Could Drive Fiscal 2026 Estimate Revisions, UBS Says MT
09/03 UBS Adjusts Price Target on Altria Group to $74 From $67 MT
04/03 Jefferies Adjusts Price Target on Altria Group to $50 From $47, Maintains Underperform Rating MT
23/02 Barclays Adjusts Price Target on Altria Group to $63 From $57, Maintains Underweight Rating MT
30/01 Stifel Adjusts Altria Group PT to $68 From $72, Maintains Buy Rating MT
26/01 UBS Adjusts Price Target on Altria Group to $67 From $63, Maintains Buy Rating MT
10/01 Altria Group Shares Rise After UBS Upgrade MT
09/01 UBS Upgrades Altria Group to Buy From Neutral, Adjusts Price Target to $63 From $61 MT
09/01 UBS Upgrades Altria Group to Buy From Neutral, Adjusts Price Target to $63 From $61 MT
04/11 Jefferies Adjusts Price Target on Altria Group to $47 From $50, Maintains Underperform Rating MT
31/25/31 UBS Adjusts Price Target on Altria Group to $61 From $68, Maintains Neutral Rating MT
01/25/01 Goldman Sachs Adjusts Price Target on Altria Group to $72 From $65, Maintains Buy Rating MT
19/25/19 US FDA to Ease Requirements on Nicotine Pouch Makers Under New Pilot Program MT
19/25/19 Exclusive-FDA nicotine pouch pilot to ease manufacturers' research burden, transcript shows RE
22/25/22 Stifel Adjusts Price Target on Altria Group to $72 From $65, Maintains Buy Rating MT
No results match your criteria